Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysisNicholas A. Vitanza, Julie R. Park, Jason K. Yokoyama et al.|Nature Medicine|2021Cited by 319
IMMU-13. PRECLINICAL EFFICACY OF MULTI-ANTIGEN (HER2/EGFR806/B7-H3/IL13RA2) TARGETING QUAD-CAR T CELLS AGAINST DIFFUSE MIDLINE GLIOMACarrie Myers, Nicholas A. Vitanza, Andrea Timpanaro et al.|Neuro-Oncology|2023Cited by 1